Implementing our guidance can generate cost savings and free up resources and capacity that can be used for other services.
Use our cost saving resource to help you assess how our guidance could benefit you.
Guidance and savings
Our resource impact reports and templates allow you to estimate savings for your local setting more accurately.
The estimated savings below are per 100,000 population and when the full uptake is achieved. The figures can be prorated, based on the total local population. This will give an estimate of the local impact.
Find out more about how we assess the resource impact of our guidance.
Savings are based on a reduction in waiting times for an abortion, ultrasounds and women having rhesus status testing and anti-D prophylaxis.
Cash savings are driven by the expected reduction in the number of patents needing stoma care. Capacity savings are made because of an increase in patients who have a CT scan upon admission.
The small cash saving is based on lower test cost. Capacity savings are based on a reduction in the number of people admitted to hospital with suspected non-ST-segment-elevation myocardial infarction.
Cash savings are as a result of reduced use of eye drops following increased routine use of selective laser trabeculoplasty (SLT).
There is also expected to be a small reduction in the number of cataract or intraocular pressure (IOP) lowering surgery procedures. These benefits outweigh the increased costs of increased SLT procedures to leave a small overall net saving.
Cash savings based on a change from total to partial knee replacements. Capacity savings are based on a reduction in revisions.
Cost savings are based on a reduction in repeat diagnostic assessments and the associated cardiology appointments.
Savings are based on a comparison to standard dressings and are evaluated on anticipated bed day savings.
Savings come from changes to the pharmacological treatments for people with acute or chronic severe sciatica.
Savings result from many areas, including an increase in shockwave lithotrips and a reduction in surgical interventions.
Savings come from reduction in the use of antithyroid drugs.
Potential savings mainly come from better healing with UrgoStart dressings. This would require fewer GP and secondary care appointments. In turn, this may lead to a reduction in amputations.
Cash savings result from changes to prescribing budgets in both primary and secondary care. Capacity savings come from a reduction in imaging screening.